In its response, the ITC stated that “Amarin’s complaint does not allege an unfair method of competition or an unfair act cognizable under 19 U.S.C. § 1337(a)(1)(A), as required by the statute and the Commission’s rules.”
Recent studies indicate magnesium’s growing importance for mental health, arterial flexibility, and metabolic function.
Recent studies show whey protein’s benefits in cases of sarcopenia, high blood pressure, and more.
The study is the latest product of a long-term collaboration that Rimfrost established with the University of Bergen for the purpose of learning more about the biological effects and mechanisms of action of proteins and lipids derived from Antarctic krill.
An expanding body of research points to the significant benefits of tocotrienols.
Manufacturers have laid the groundwork to succeed in the fast-growing high-flavanol cocoa category, but there is work still to be done to show consumers that high-flavanol products are more than just desserts.
Do calcium supplements really increase cardiovascular risk? Here’s what the latest research says.
NattoPharma (Oslo, Norway) unveiled its latest vitamin K2 innovation yet at this year’s SupplySide West trade show: the industry’s first and only full-spectrum vitamin K2 ingredient that comprehensively provides menaquinones (MK) 6, 7, 8, and 9, all vital to heart health.
Will brands and formulators have to do better than simply offering higher concentrates in order to keep consumer interested in omega-3s supplements?
CRN Asks International Trade Commission to Reject Amarin’s Omega-3 Complaint, Citing Legal Deficiencies, Harm to Public Interest
In two filings submitted to the International Trade Commission, CRN argued that Amarin was “financially motivated” to expand its near monopoly over a subset of omega-3 products; if successful, CRN says, Amarin’s complaint would make it much more difficult and costly for consumers to access those products.